Results 231 to 240 of about 22,651 (250)

The uncertainty period preceding the clinical defined SPMS diagnosis and the applicability of objective classifiers – A Danish single center study

Multiple Sclerosis and Related Disorders, 2023
Background: The clinical transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive MS (SPMS) is often related to a period of diagnostic uncertainty delaying diagnosis.
Melinda Magyari, Finn Sellebjerg, Luigi Pontieri   +2 more
exaly   +2 more sources

Assessment of serum inflammatory parameters in RRMS and SPMS patients

Neurological Research
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease. Patients with relapsing–remitting MS (RRMS) and secondary progressive MS (SPMS) differ in their responses to treatment; therefore, the correct diagnosis of the particular type of MS is
Krzysztof Wierzbicki, Monika Adamczyk-Sowa, Maria Nowak-Kiczmer   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response

International Journal of Molecular Sciences, 2021
Pedro-Antonio Regidor, Manuela Sailer
exaly  

PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs)

Biomedicines, 2022
Pedro-Antonio Regidor, Xavier de la Rosa Siles   +1 more
exaly  

Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND study

Multiple Sclerosis and Related Disorders, 2023
Fred Lublin, Amit Bar-Or, Le Hua
exaly  

E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition

Seminars in Immunology, 2022
Stephania Libreros, Robert Nshimiyimana, Charles N Serhan   +2 more
exaly  

Characterization of Patient and Treatment Characteristics in SPMS and at Risk for SPMS Patients in Clinical Routine: The PANGAEA 2.0 EVOLUTION Study (2148)

Neurology, 2021
Tjalf Ziemssen
exaly  

A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians’ and patients’ views

Multiple Sclerosis and Related Disorders, 2020
Tjalf Ziemssen, Davorka Lucia Tomić, James Pike   +2 more
exaly  

A new morphological approach for removing acid dye from leather waste water: Preparation and characterization of metal-chelated spherical particulated membranes (SPMs)

Journal of Environmental Management, 2015
Ahmet Aslan, Sinan Akgöl
exaly